Polydox / PolyMVA

<p>Available<a href="https://www.thetruthbehindcancerstore.com/product/poly-mva"> here</a></p>

<p>There is no scientific evidence to support the following claims:

To treat asthma
To treat cancer
To treat chronic fatigue syndrome
To treat HIV and AIDS
To treat psoriasis
To treat systemic lupus erythematosus (SLE)</p>

<p><a href="https://www.mskcc.org/cancer-care/integrative-medicine/herbs/polydox">Per Sloan-Kettering</a></p>

<h2>Clinical Summary</h2>

<p>Polydox is a synthetic product containing lipoic acid-palladium complex (LAPd) and B complex vitamins. Patients use it to treat cancer, HIV/AIDS, chronic fatigue syndrome, psoriasis, and other degenerative disorders. Studies done in animals indicate that Polydox has neuroprotective , radioproctective , antidiabetic and antioxidant properties. Polydox has not been evaluated in clinical trials.</p>

<h2>Mechanism of Action</h2>

<p>The inventor of Polydox claims that it is a metalo-vitamin with antioxidant activity capable of repairing damaged genes. Polydox is said to have DNA reductase and electro-active properties that alter electron flow in cancer cells at the mitochondrial level, resulting in cytotoxicity. The manufacturer reports benefits for cancer patients such as increases in energy and appetite, and reduction in cancer-related pain . However, no independent scientific data support these claims.</p>

<p>
Studies in rats show palladium-alpha-lipoic acid complex protects the aging of myocardium by enhancing the Krebs cycle dehydrogenases and mitochondrial electron transport chain complexes . It increases the level of glutathione and reduces the level of lipid peroxidation . Palladium-alpha-lipoic acid complex also protects against radiation-induced cellular damages in animals.</p>

<h2>Studies</h2>

<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?itool=abstractplus%26db=pubmed%26cmd=Retrieve%26dopt=abstractplus%26list_uids=15296831" target="_blank">Regulation of ischemic cell death by the lipoic acid-palladium complex, Poly MVA, in gerbils</a></p>

<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/20701542" target="_blank">Radioprotection by alpha-lipoic acid palladium complex formulation (POLY-MVA) in mice</a></p>

<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/19500641" target="_blank">Palladium alpha-lipoic acid complex formulation enhances activities of Krebs cycle dehydrogenases and respiratory complexes I-IV in the heart of aged rats.</a></p>

<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/20412826" target="_blank">Effect of POLY-MVA, a palladium alpha-lipoic acid complex formulation against declined mitochondrial antioxidant status in the myocardium of aged rats</a></p>

<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/21679354" target="_blank">Palladium-α-lipoic acid complex attenuates alloxan-induced hyperglycemia and enhances the declined blood antioxidant status in diabetic rats</a></p>

<h2>Drug Interactions</h2>

<p>Polydox’s antioxidant activity may interfere with the actions of certain chemotherapeutic agents</p>

Polydox / PolyMVA

Attachments